Logo image of C3RY.DE

CHERRY SE (C3RY.DE) Stock Fundamental Analysis

FRA:C3RY - Deutsche Boerse Ag - DE000A3CRRN9 - Common Stock - Currency: EUR

0.886  +0.01 (+0.68%)

Fundamental Rating

2

C3RY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 27 industry peers in the Technology Hardware, Storage & Peripherals industry. C3RY may be in some trouble as it scores bad on both profitability and health. C3RY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year C3RY has reported negative net income.
C3RY had a negative operating cash flow in the past year.
In the past 5 years C3RY reported 4 times negative net income.
C3RY had a positive operating cash flow in 4 of the past 5 years.
C3RY.DE Yearly Net Income VS EBIT VS OCF VS FCFC3RY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -31.97%, C3RY is doing worse than 85.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of -67.06%, C3RY is doing worse than 74.07% of the companies in the same industry.
Industry RankSector Rank
ROA -31.97%
ROE -67.06%
ROIC N/A
ROA(3y)-29.88%
ROA(5y)-18%
ROE(3y)-58.91%
ROE(5y)-35.77%
ROIC(3y)N/A
ROIC(5y)N/A
C3RY.DE Yearly ROA, ROE, ROICC3RY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80 -100

1.3 Margins

C3RY has a worse Gross Margin (19.38%) than 74.07% of its industry peers.
In the last couple of years the Gross Margin of C3RY has declined.
The Profit Margin and Operating Margin are not available for C3RY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.07%
GM growth 5YN/A
C3RY.DE Yearly Profit, Operating, Gross MarginsC3RY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

C3RY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, C3RY has about the same amount of shares outstanding.
C3RY has a better debt/assets ratio than last year.
C3RY.DE Yearly Shares OutstandingC3RY.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
C3RY.DE Yearly Total Debt VS Total AssetsC3RY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -1.62, we must say that C3RY is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.62, C3RY is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.50 indicates that C3RY is somewhat dependend on debt financing.
C3RY has a Debt to Equity ratio (0.50) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Altman-Z -1.62
ROIC/WACCN/A
WACC5.74%
C3RY.DE Yearly LT Debt VS Equity VS FCFC3RY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

C3RY has a Current Ratio of 2.38. This indicates that C3RY is financially healthy and has no problem in meeting its short term obligations.
C3RY has a better Current ratio (2.38) than 74.07% of its industry peers.
A Quick Ratio of 0.82 indicates that C3RY may have some problems paying its short term obligations.
With a Quick ratio value of 0.82, C3RY is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 0.82
C3RY.DE Yearly Current Assets VS Current LiabilitesC3RY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 61.22% over the past year.
C3RY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.62%.
C3RY shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.14% yearly.
EPS 1Y (TTM)61.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.57%
Revenue 1Y (TTM)-17.62%
Revenue growth 3Y-13.14%
Revenue growth 5YN/A
Sales Q2Q%-16.38%

3.2 Future

C3RY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.98% yearly.
The Revenue is expected to grow by 2.13% on average over the next years.
EPS Next Y61.64%
EPS Next 2Y34.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.93%
Revenue Next 2Y5.85%
Revenue Next 3Y3.64%
Revenue Next 5Y2.13%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
C3RY.DE Yearly Revenue VS EstimatesC3RY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
C3RY.DE Yearly EPS VS EstimatesC3RY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

C3RY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for C3RY. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
C3RY.DE Price Earnings VS Forward Price EarningsC3RY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
C3RY.DE Per share dataC3RY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

C3RY's earnings are expected to grow with 34.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.98%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

C3RY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CHERRY SE

FRA:C3RY (7/28/2025, 7:00:00 PM)

0.886

+0.01 (+0.68%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-14 2023-08-14/bmo
Earnings (Next)N/A N/A
Inst Owners30.69%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.53M
Analysts44
Price Target0.92 (3.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.3
P/tB 2.14
EV/EBITDA N/A
EPS(TTM)-2.03
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS4.34
BVpS2.94
TBVpS0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.97%
ROE -67.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.38%
FCFM N/A
ROA(3y)-29.88%
ROA(5y)-18%
ROE(3y)-58.91%
ROE(5y)-35.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.07%
GM growth 5YN/A
F-Score5
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 25.27%
Cap/Sales 7.96%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 0.82
Altman-Z -1.62
F-Score5
WACC5.74%
ROIC/WACCN/A
Cap/Depr(3y)17.41%
Cap/Depr(5y)38.92%
Cap/Sales(3y)6.91%
Cap/Sales(5y)6.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)61.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-78.57%
EPS Next Y61.64%
EPS Next 2Y34.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.62%
Revenue growth 3Y-13.14%
Revenue growth 5YN/A
Sales Q2Q%-16.38%
Revenue Next Year4.93%
Revenue Next 2Y5.85%
Revenue Next 3Y3.64%
Revenue Next 5Y2.13%
EBIT growth 1Y44.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y44.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y72.31%
OCF growth 3Y-28.61%
OCF growth 5YN/A